Evommune (EVMN) Times Interest Earned (2024 - 2026)
Evommune's (EVMN) quarterly Times Interest Earned came in at -$0.26 in Q1 2026, up 99.65% year-on-year from -$0.13 in Q1 2025, and down 100.34% on a QoQ basis from $75.61 in Q4 2025.
Evommune (EVMN) Times Interest Earned (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Times Interest Earned data on file, last reported at -$0.26 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 99.65% year-over-year to -$0.26 in Q1 2026; TTM through Mar 2026 was -$0.89, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.49, up 98.3% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.26, down from $75.61 in the prior quarter.
- Over the last five years, Times Interest Earned for EVMN reached as high as $75.61 in Q4 2025 and fell as low as -$971.59 in Q3 2024.
- Historically, Times Interest Earned has averaged -$155.87 across 3 years, with a median of -$1.09 in 2025.
- On a YoY basis, Times Interest Earned climbed as much as 99.8% in 2025 and fell as far as 98.43% in 2025.
- Year by year, Times Interest Earned stood at $38.11 in 2024, then soared by 98.43% to $75.61 in 2025, then plunged by 100.34% to -$0.26 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.26 in Q1 2026, $75.61 in Q4 2025, and -$1.93 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -157.58 |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 3.88 |
| 10 | Evommune | 391.25 Mn | 179.78 Mn | - | -0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26 |
| Dec 31, 2025 | 75.61 |
| Sep 30, 2025 | -1.93 |
| Mar 31, 2025 | -75.16 |
| Dec 31, 2024 | 38.11 |
| Sep 30, 2024 | -971.59 |